Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 401-620-8 | CAS number: 87731-18-8 VIOLIFF
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 01, 1985 - November 14, 1985
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (1982)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Methoxycarbonyloxycyclooct-4-ene
- EC Number:
- 401-620-8
- EC Name:
- Methoxycarbonyloxycyclooct-4-ene
- Cas Number:
- 87731-18-8
- Molecular formula:
- C10H16O3
- IUPAC Name:
- (1R,3aS,6aS)-octahydropentalen-1-yl methyl carbonate; (1S,3aS,6aS)-octahydropentalen-1-yl methyl carbonate; (3Z)-cyclooct-3-en-1-yl methyl carbonate; (4Z)-cyclooct-4-en-1-yl methyl carbonate; bicyclo[3.2.1]octan-8-yl methyl carbonate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River U.K. Limited, Margate, Kent, UK.
- Age at study initiation: no data available
- Weight at study initiation: between 22 and 24 grams on arrival
- Assigned to test groups randomly: yes
- Fasting period before study: no data available
- Housing: 2 or 5 animals in plastic disposable cages
- Diet (e.g. ad libitum): free access to Labsure LAD 1 rodent diet
- Water (e.g. ad libitum): free access to tap water
- Acclimation period: approximately 4 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): no data available
- Air changes (per hr): 30
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: corn oil (obtained from Macarthy's Ltd.)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
- Solutions of cyclooctenyl methyl carbonate were prepared just prior to use.
- Concentrations of the dosing formulations prepared were as follows:
For the preliminary toxicity test: 2, 4, 8, 16 and 32 mg/mL/400, 800, 1600, 3200 and 6400 mg/kg (phase I), and 16, 20, 25 and 31.25 mg/mL/3200, 4000, 5000 and 6250 mg/kg (phase II)
For the micronucleus test: 142.5 mg/mL
- All animals in all groups were dosed with the standard volume of 20 mL/kg bodyweight. - Duration of treatment / exposure:
- 24, 48 and 72 hours (solvent control and test substance)
24 hours (postive control) - Frequency of treatment:
- Once
Doses / concentrations
- Dose / conc.:
- 2 850 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5/time point
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Mitomycin C
- Route of administration: oral gavage
- Doses / concentrations: 8 mg/kg bodyweight / 0.4 mg/mL
Examinations
- Tissues and cell types examined:
- - Incidence of micronucleated cells per 1000 polychromatic erythrocytes.
- The ratio of polychromatic to normochromatic erythrocytes by examination of at least 1000 erythrocytes.
- The number of micronucleated normochromatic erythrocytes - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
From the results obtained in the preliminary toxicity study, a dosage of 2850 mg per kg bodyweight was chosen for the micronucleus test.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Five males and five females from the negative control and test compound groups were sacrificed 24, 48 and 72 hours after dosing.
The positive control group was sacrificed 24 hours after dosing.
DETAILS OF SLIDE PREPARATION:
The animals were killed by cervical dislocation and both femurs dissected out from each animal. The femurs were cleared of tissue and one epiphysis removed from each bone. A direct bone marrow smear was made onto a slide containing a drop of calf serum. One smear was made from each femur. The prepared smears were air-dried and fixed in methanol. After fixation, the smears were air-dried and stained using Giemsa's technique. After rinsing in buffered distilled water (pH 6.8), the slides were air-dried and mounted with coverslips using DPX.
METHOD OF ANALYSIS:
The stained smears were examined (under code) by light microscopy. - Evaluation criteria:
- Any statistically significant increases in the number of micronucleated polychromatic erythrocytes at any sampling time.
- Statistics:
- Wilcoxon's sum of ranks test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- at the 48 hour sampling time
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY:
The mortality data were subjected to probit analysis which indicated that a dose of 2850 mg/kg would be expected to kill approximately 10% of the animals over the 72 hour exposure period (LD 50 was estimated as 4485 mg/kg). A dosage of 2850 mg per kg bodyweight was chosen for use in the main test.
RESULTS OF DEFINITIVE STUDY:
- Mortalities: No animals died after treatment with cyclooctenyl methyl carbonate in the main study.
- Clinical signs included: pilo-erection, hunched posture, lethargy, decreased respiratory rate, ptosis, pallor of extremities and ataxia.
- Micronucleated polychromatic erythrocyte counts: the substance did not cause any statistically significant increases in the number of micronucleated polychromatic erythrocytes at any of the three sampling times - P>0.05 using Wilcoxon's sum of ranks test. Mitomycin C caused large, highly significant increases (P<0.001) in the frequency of micronucleated polychromatic erythrocytes.
- Micronucleated normochromatic erythrocytes: the substance did not cause any substantial increases in the incidence of micronucleated normochromatic erythrocytes at any of the three sampling times.
- Ratio of polychromatic to normochromatic erythrocytes: At the 48 hour sampling time, slight but statistically significant decreases in the ratio were observed after treatment with the substance. Significant decreases were not obtained at the 24 and 72 hour sampling times. The results suggest that the substance may have a slight cytotoxic activity towards bone marrow. Mytomycin C caused statistically significant decreases in the ratio.
Applicant's summary and conclusion
- Conclusions:
- The substance was not clastogenic in the in vivo micronucleus test (OECD TG 474).
- Executive summary:
The substance was tested in the in vivo micronucleus test (OECD TG 474). After a preliminary test to determine test concentrations, male and female mice were dosed with 2850 mg/kg. Three sampling times (24, 48 and 72 hours) were used. No animals died after treatment. The substance did not cause any substantial increases in the incidence of micronucleated normochromatic or polychromatic erythrocytes. The substance only caused slight but statistically significant decreases in the ratio of polychromatic to normochromatic erythrocytes at the 48 h sampling times suggesting that the substance has a cytotoxic activity towards bone marrow. Based on the results, the substance is not clastogenic in this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.